Muhammed Majeed, Ph.D., Founder &
CEO
The 1990s witnessed phenomenal growth in nutraceutical
markets across the world.
Sabinsa Corporation pioneered the introduction of several
nutraceutical raw materials of Indian origin to global
markets, during this phase. We now stand at the threshold
of a maturing market that increasingly demands scientific
foundations. With over a hundred scientists dedicated
to herbal extracts and plant methodologies, we stand
at the forefront of these challenges.
Quality and excellence have been, and will continue
to be, the guiding principles behind our efforts to
bring time-tested nutraceutical ingredients to the expanding
marketplace. Our research efforts span all areas of
nutraceutical development – cultivation, collection,
processing, standardization, analytical methodology
and storage stability. Our manufacturing facilities
have been upgraded to include state of the art processing
technology such as supercritical fluid extraction, to
meet global regulatory needs.
In light of media reports that reflect poorly on the
nutraceutical industry, increased emphasis on quality
and innovation is warranted. We meet this challenge
through developing research driven products with claims
that can be patented and commercialized. Our research
groups both in India and the US, work toward developing
novel ingredients and processes, to meet a wider range
of preventive health maintenance needs.
This year, we were granted a US patent for Gugulipid®,
that describes the role of this versatile natural extract
in preventing inflammation and tumor development. Over
14 other patent applications related to natural extracts
and nutritional fine chemicals filed in 2001-2002, are
currently being processed.
As always, we will continue to foster the tradition
of quality and innovation that you have come to expect
from SABINSA, in the coming year and in the years to
come.
I take this opportunity to wish you all a Happy and
Healthy Holiday Season.
|
